"Interleukin-4" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.
| Descriptor ID |
D015847
|
| MeSH Number(s) |
D12.644.276.374.465.186 D12.776.467.374.465.178 D23.529.374.465.186
|
| Concept/Terms |
Interleukin-4- Interleukin-4
- Interleukin 4
- B-Cell Growth Factor-1
- B Cell Growth Factor 1
- B-Cell Growth Factor-I
- B Cell Growth Factor I
- B-Cell Proliferating Factor
- B Cell Proliferating Factor
- B-Cell Stimulating Factor-1
- B Cell Stimulating Factor 1
- B-Cell Stimulatory Factor 1
- B-Cell Stimulatory Factor-1
- BCGF-1
- Binetrakin
- BSF-1
- IL-4
- IL4
- Mast Cell Growth Factor-2
- Mast Cell Growth Factor 2
- MCGF-2
- B Cell Stimulatory Factor-1
- B Cell Stimulatory Factor 1
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-4".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-4".
This graph shows the total number of publications written about "Interleukin-4" by people in this website by year, and whether "Interleukin-4" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 3 | 6 |
| 1996 | 5 | 3 | 8 |
| 1997 | 5 | 4 | 9 |
| 1998 | 1 | 3 | 4 |
| 1999 | 5 | 6 | 11 |
| 2000 | 1 | 5 | 6 |
| 2001 | 5 | 10 | 15 |
| 2002 | 2 | 6 | 8 |
| 2003 | 1 | 7 | 8 |
| 2004 | 0 | 4 | 4 |
| 2005 | 2 | 6 | 8 |
| 2006 | 0 | 5 | 5 |
| 2007 | 1 | 5 | 6 |
| 2008 | 1 | 7 | 8 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 10 | 10 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 6 | 6 |
| 2013 | 1 | 3 | 4 |
| 2014 | 0 | 5 | 5 |
| 2015 | 1 | 3 | 4 |
| 2016 | 3 | 3 | 6 |
| 2017 | 1 | 2 | 3 |
| 2018 | 3 | 2 | 5 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 1 | 4 | 5 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-4" by people in Profiles.
-
[Zhuyu Pills promote polarization of macrophages toward M2 phenotype to prevent atherosclerosis via PPAR?/NF-?B signaling pathway]. Zhongguo Zhong Yao Za Zhi. 2024 Jan; 49(1):243-250.
-
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):873-884.e11.
-
Introducing a New Method for Purification of Human IL-4 by Substitution of a Single Amino Acid in IL-4 Protein Sequence. Iran J Immunol. 2022 12; 19(4):436-445.
-
Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios. Mult Scler Relat Disord. 2022 Dec; 68:104239.
-
Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7. Front Immunol. 2022; 13:1020902.
-
A novel multi-epitope recombinant protein elicits an antigen-specific CD8+?T cells response in Trypanosoma cruzi-infected mice. Vaccine. 2022 10 26; 40(45):6445-6449.
-
Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke. J Cereb Blood Flow Metab. 2022 10; 42(10):1827-1839.
-
LmjMAPK10 offers protection against Leishmania donovani infection. Parasite Immunol. 2020 02; 42(2):e12687.
-
Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine. 2020 02; 126:154866.
-
Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice. Mol Ther. 2020 01 08; 28(1):254-265.